Prime Medicine, Common Etf Price on January 22, 2024
| PRME Etf | USD 3.29 0.01 0.30% |
If you're considering investing in Prime Etf, it is important to understand the factors that can impact its price. As of today, the current price of Prime Medicine, stands at 3.29, as last reported on the 1st of December, with the highest price reaching 3.41 and the lowest price hitting 3.27 during the day. Prime Medicine, Common maintains Sharpe Ratio (i.e., Efficiency) of -0.0247, which implies the entity had a -0.0247% return per unit of risk over the last 3 months. Prime Medicine, Common exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Prime Medicine,'s Risk Adjusted Performance of (0.03), variance of 26.22, and Coefficient Of Variation of (2,067) to confirm the risk estimate we provide.
Prime Etf price history is provided at the adjusted basis, taking into account all of the recent filings.
Prime |
Sharpe Ratio = -0.0247
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PRME |
Estimated Market Risk
| 5.05 actual daily | 44 56% of assets are more volatile |
Expected Return
| -0.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Prime Medicine, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Prime Medicine, by adding Prime Medicine, to a well-diversified portfolio.
Price Book 2.2771 | Enterprise Value Ebitda (3.10) | Price Sales 541.0405 | Shares Float 60.4 M | Wall Street Target Price 12.6364 |
Prime Medicine, Valuation on January 22, 2024
It is possible to determine the worth of Prime Medicine, on a given historical date. On January 22, 2024 Prime was worth 6.6 at the beginning of the trading date compared to the closed value of 6.7. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Prime Medicine, etf. Still, in general, we apply an absolute valuation method to find Prime Medicine,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Prime Medicine, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Prime Medicine,'s related companies.
| Open | High | Low | Close | Volume | |
| 6.39 | 6.58 | 6.26 | 6.50 | 524,500 | |
01/22/2024 | 6.60 | 6.85 | 6.45 | 6.70 | 707,500 |
| 6.77 | 6.89 | 6.48 | 6.61 | 478,100 |
| Backtest Prime Medicine, | | | Prime Medicine, History | | | Prime Medicine, Valuation | Previous | Next |
Prime Medicine, Trading Date Momentum on January 22, 2024
| On January 23 2024 Prime Medicine, Common was traded for 6.61 at the closing time. The top price for the day was 6.89 and the lowest listed price was 6.48 . The trading volume for the day was 478.1 K. The trading history from January 23, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.34% . The trading delta at closing time against the current closing price is 3.88% . |
Prime Medicine, Common Fundamentals Correlations and Trends
By evaluating Prime Medicine,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Prime Medicine,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Prime financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Prime Medicine, Etf history
Prime Medicine, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Prime is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Prime Medicine, Common will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Prime Medicine, stock prices may prove useful in developing a viable investing in Prime Medicine,
Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. Prime Medicine is listed under Biotechnology in the United States and is traded on NASDAQ Exchange exchange.
Prime Medicine, Quarterly Net Working Capital |
|
Prime Medicine, Etf Technical Analysis
Prime Medicine, technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
Price Boundaries
Prime Medicine, Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
Prime Medicine, Common cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Prime Medicine, December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how Prime Medicine, etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Prime Medicine, shares will generate the highest return on investment. By undertsting and applying Prime Medicine, etf market strength indicators, traders can identify Prime Medicine, Common entry and exit signals to maximize returns
Prime Medicine, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Prime Medicine,'s price direction in advance. Along with the technical and fundamental analysis of Prime Etf historical price patterns, it is also worthwhile for investors to track various predictive indicators of Prime to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.51) | |||
| Total Risk Alpha | (1.11) | |||
| Treynor Ratio | (0.13) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Other Information on Investing in Prime Etf
Prime Medicine, financial ratios help investors to determine whether Prime Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Prime with respect to the benefits of owning Prime Medicine, security.